12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. First Wave BioPharma, Cingulate, NKGen Biotech, Cytokinetics, Coherus BioSciences, and Opthea saw their stocks rise by 119.2%, 83.83%, 51.41%, 43.29%, 41.28%, and 25.0% respectively. Conversely, Iovance Biotherapeutics, IMAC Holdings, Biophytis, SINTX Techs, Yield10 Bioscience, and Onconetix experienced declines in their stock prices.
December 27, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coherus BioSciences' shares increased by 41.28% to $3.08, with a market cap of $343.0 million.
The surge in CHRS stock suggests positive developments that could lead to further short-term price increases.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cingulate's stock increased by 83.83% to $3.64, with a market cap of $3.4 million.
Cingulate's significant pre-market rise suggests positive investor sentiment, which may result in continued short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Cytokinetics' stock went up by 43.29% to $65.5, with a market cap of $6.4 billion.
Cytokinetics' notable pre-market increase may attract more investors, potentially driving the stock higher in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
First Wave BioPharma's stock soared 119.2% to $8.09 with a market cap of $5.4 million.
The substantial pre-market gain for FWBI indicates strong investor interest, likely due to positive news or expectations, which could lead to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
NKGen Biotech's stock rose by 51.41% to $4.27, with a market cap of $93.4 million.
The sharp increase in NKGN's stock price could indicate market optimism, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Opthea's shares rose by 25.0% to $3.15, with a market value of $260.9 million.
Opthea's stock rise indicates investor confidence, which may continue to push the stock up in the short term.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
IMAC Holdings' shares decreased by 13.96% to $2.96, with a market cap of $3.3 million.
IMAC Holdings' stock decline suggests potential negative factors at play, which may result in further short-term depreciation.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Biophytis' stock fell by 9.88% to $0.72, with a market cap of $7.0 million.
The pre-market drop in BPTS stock could indicate investor concerns, potentially leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Iovance Biotherapeutics' stock dropped 26.3% to $6.55, with a market cap of $1.6 billion.
The significant pre-market decline for IOVA could reflect negative sentiment or news, likely leading to a short-term downtrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Onconetix's shares fell 8.43% to $0.19, with a market cap of $3.6 million.
Onconetix's stock price drop suggests a bearish outlook, which may persist in the short term.
CONFIDENCE 85
IMPORTANCE 40
RELEVANCE 100
NEGATIVE IMPACT
SINTX Techs' stock declined by 9.18% to $0.43, with a market value of $1.8 million.
SINTX Techs' stock decrease may reflect negative market sentiment, suggesting a possible continuation of the downtrend in the short term.
CONFIDENCE 85
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Yield10 Bioscience's shares fell 8.55% to $0.2, with a market value of $2.4 million.
The decline in YTEN shares could signal underlying issues, potentially leading to further short-term negative performance.
CONFIDENCE 85
IMPORTANCE 45
RELEVANCE 100